Literature DB >> 12404597

Phospholipid metabolism and depression: the possible roles of phospholipase A2 and coenzyme A-independent transacylase.

David F Horrobin1.   

Abstract

Phospholipids make up 60 per cent of the dry weight of the brain. They are essential for neuronal and especially for synaptic structure and play key roles in the signal transduction responses to dopamine, serotonin, glutamate and acetyl choline. The unsaturated fatty acid components of phospholipids are abnormal in depression, with deficits of eicosapentaenoic acid and other omega-3 fatty acids and excesses of the omega-6 fatty acid arachidonic acid. Correction of this abnormality by treatment with eicosapentaenoic acid improves depression. The fatty acid abnormalities provide a rational explanation for the associations of depression with cardiovascular disease, immunological activation, cancer, diabetic complications and osteoporosis. The abnormalities cannot be explained by diet, although diet may attenuate or exacerbate their consequences. A number of enzyme abnormalities could explain the phenomena: phospholipase A(2), and coenzyme A-independent transacylase are strong candidates. Copyright 2001 John Wiley & Sons, Ltd.

Entities:  

Year:  2001        PMID: 12404597     DOI: 10.1002/hup.182

Source DB:  PubMed          Journal:  Hum Psychopharmacol        ISSN: 0885-6222            Impact factor:   1.672


  9 in total

1.  Biomarkers and clinical staging in psychiatry.

Authors:  Patrick McGorry; Matcheri Keshavan; Sherilyn Goldstone; Paul Amminger; Kelly Allott; Michael Berk; Suzie Lavoie; Christos Pantelis; Alison Yung; Stephen Wood; Ian Hickie
Journal:  World Psychiatry       Date:  2014-10       Impact factor: 49.548

Review 2.  Tranylcypromine: new perspectives on an "old" drug.

Authors:  Helge Frieling; Stefan Bleich
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2006-08       Impact factor: 5.270

Review 3.  Omega-3 fatty acids in depression: a review of three studies.

Authors:  Yamima Osher; R H Belmaker
Journal:  CNS Neurosci Ther       Date:  2009       Impact factor: 5.243

Review 4.  The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression.

Authors:  Michael Maes; Raz Yirmyia; Jens Noraberg; Stefan Brene; Joe Hibbeln; Giulia Perini; Marta Kubera; Petr Bob; Bernard Lerer; Mario Maj
Journal:  Metab Brain Dis       Date:  2008-12-16       Impact factor: 3.584

5.  The role of vitamins and minerals in psychiatry.

Authors:  Stacey Cornish; Lewis Mehl-Madrona
Journal:  Integr Med Insights       Date:  2008-09-24

Review 6.  N-3 Polyunsaturated Fatty Acids through the Lifespan: Implication for Psychopathology.

Authors:  Matteo M Pusceddu; Philip Kelly; Catherine Stanton; John F Cryan; Timothy G Dinan
Journal:  Int J Neuropsychopharmacol       Date:  2016-12-30       Impact factor: 5.176

7.  Novel Phospholipid Signature of Depressive Symptoms in Patients With Coronary Artery Disease.

Authors:  Parco Chan; Ivonne Suridjan; Dana Mohammad; Nathan Herrmann; Graham Mazereeuw; Lyn M Hillyer; David W L Ma; Paul I Oh; Krista L Lanctôt
Journal:  J Am Heart Assoc       Date:  2018-05-05       Impact factor: 5.501

Review 8.  Peripheral Markers of Depression.

Authors:  Aleksander Nobis; Daniel Zalewski; Napoleon Waszkiewicz
Journal:  J Clin Med       Date:  2020-11-24       Impact factor: 4.241

9.  Serum metabolomics of end-stage renal disease patients with depression: potential biomarkers for diagnosis.

Authors:  Dezhi Yuan; Tian Kuan; Hu Ling; Hongkai Wang; Liping Feng; Qiuye Zhao; Jinfang Li; Jianhua Ran
Journal:  Ren Fail       Date:  2021-12       Impact factor: 2.606

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.